by rdbiomed | Apr 6, 2021 | Company Updates
Professor Peter Dettmar and Professor Jeffery Pearson, world renowned experts in pepsin, will present key papers on gastroesophageal reflux disease in an international journal. Annals of Esophagus publishes leading-edge findings, techniques and opinions in all fields... 
by rdbiomed | Mar 8, 2021 | Company Updates
Professor Peter Dettmar has shared insight into how prevalent gastroesophageal reflux disease (GERD) is across the world in an article published in the international journal Annals of Esophagus. His narrative review, written in collaboration with Katie Boulton, looks... 
by rdbiomed | Mar 5, 2021 | Company Updates, Latest Pepsin Research
We’re excited to hear that Peptest has proved valuable in helping identify symptoms of ‘silent reflux’ at NHS respiratory clinics at the Bristol Royal Infirmary. Many people associate reflux with symptoms, such as heartburn or acid reflux, but it can also cause... 
by rdbiomed | Feb 22, 2021 | Company Updates
Peptest and the importance of salivary pepsin detection was put under the spotlight at a forum in China, attended by our distributor Maxhealth. The 13th China Cough Forum and the 13th National Class on Chronic Cough and Difficult and Rare Diseases took place in... 
by rdbiomed | Jan 8, 2021 | Company Updates
Professor Peter Dettmar has provided insight into the diagnosis and treatment of reflux disease to a virtual and offline conference of key opinion leaders in China. His presentation featured at the virtual 2020 Annual Meeting of the Gastroesophageal Reflux... 
by rdbiomed | Sep 14, 2020 | Company Updates
Peptest could prove useful during the current Covid-19 pandemic when access to clinics and more complex clinical diagnostic procedures is restricted or delayed. Many non-essential medical procedures have been postponed or cancelled during the Covid-19 pandemic, with...
Recent Comments